Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine
NCT ID: NCT00777218
Last Updated: 2020-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2007-08-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
NCT00131443
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children
NCT00210535
A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
NCT00158002
A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
NCT00236561
A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children
NCT00237302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
propranolol
standard pediatric doses, based on body weight
2
zonisamide
standard pediatric dosages, based on body weight
3
topiramate
standard pediatric dosages, based on body weight
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
propranolol
standard pediatric doses, based on body weight
zonisamide
standard pediatric dosages, based on body weight
topiramate
standard pediatric dosages, based on body weight
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subjects must between the age of 8-17 (inclusive)
Exclusion Criteria
8 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of South Alabama
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. I. Lopez, MD
Role: PRINCIPAL_INVESTIGATOR
University of South Alabama Department of Neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of South Alabama Department of Neurology
Mobile, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-185
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.